• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Fennec Pharmaceuticals Inc (NQ: FENC )

    6.000 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 100
    Open 6.000
    Bid (Size) 5.770 (1)
    Ask (Size) 7.300 (1)
    Prev. Close 6.000
    Today's Range 6.000 - 6.000
    52wk Range 5.660 - 11.92
    Shares Outstanding 27,099,908
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    FENC Stock Earnings: Fennec Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
    FENC stock results show that Fennec Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -46.04%
    -46.04%
    1 Month
    -15.49%
    -15.49%
    3 Month
    -43.77%
    -43.77%
    6 Month
    -41.69%
    -41.69%
    1 Year
    -31.90%
    -31.90%

    More News

    Read More
    FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Fennec Pharmaceuticals's Earnings Outlook
    Via Benzinga
    Earnings Scheduled For November 6, 2023
    Via Benzinga
    Preview: Fennec Pharmaceuticals's Earnings
    Via Benzinga
    Analyst Ratings for Fennec Pharmaceuticals
    Via Benzinga
    Earnings Scheduled For March 21, 2024
    Via Benzinga
    Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Highlighted for Surprising Price Action
    Via Investor Brand Network
    Recap: Fennec Pharmaceuticals Q1 Earnings
    Via Benzinga
    Earnings Outlook For Fennec Pharmaceuticals
    Via Benzinga
    Analyst Ratings for Fennec Pharmaceuticals
    Via Benzinga
    Expert Ratings for Fennec Pharmaceuticals
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Fennec Pharmaceuticals
    Via Benzinga
    Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Making Surprising Moves in Monday Session
    Via Investor Brand Network
    7 Biotech Stocks Sitting in the Sweet Spot
    Via InvestorPlace
    US Stocks Open Lower; Dow Dips 250 Points
    Via Benzinga
    4 Analysts Have This to Say About Fennec Pharmaceuticals
    Via Benzinga
    Where Fennec Pharmaceuticals Stands With Analysts
    Via Benzinga
    After Two FDA Rejections, Fennec Pharma Lead Drug Scores US Approval For Chemo-Induced Hearing Loss
    Via Benzinga
    Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
    Via Benzinga
    Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
    Via Benzinga
    Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
    Via Benzinga
    NASDAQ:FENC Long Term Shareholder Notice: Investigation over Possible Wrongdoing at Fennec Pharmaceuticals Inc.
    Via SBWire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.